A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.
Takayuki JodaiChieko YoshidaRyo SatoYosuke KakiuchiNahoko SatoShinji IyamaTomoko KimuraKoichi SaruwatariSho SaekiHidenori IchiyasuKazuhiko FujiiYusuke TomitaPublished in: Immunity, inflammation and disease (2018)
Given the increasing frequency of the use of anti-PD-1 antibodies, clinicians should be aware of the risk of AEP as a potential irAE. This study may improve our understanding of the pathophysiology underlying Th2-associated irAEs and AEP.